• Blog
  • Hemodialysis Catheters Market Growth Analysis

    Hemodialysis Catheters Market Growth Analysis

    Hemodialysis Catheters Market Growth Analysis
    Report code - SR2173 Delivery - 2 Weeks
    Hemodialysis Catheters Market Size, Share, Trend, Forecast, Competitive Analysis, and Grow See more...

    Market Insights

    The Hemodialysis Catheters Market is estimated at US$ 823 million in 2021 and is expected to grow at a CAGR of 4.8% during 2022-2028 to reach US$ ~1140 million in 2028.

    Wish to get a free sample? Register Here

    What is a hemodialysis catheter?

    A hemodialysis catheter is a piece of medical equipment that is put into the body during hemodialysis to reach the intravascular area. A specific filter called a dialyzer is where the blood from the body is cleansed before being returned to the body through the hemodialysis catheter.

    The easy-to-use double-lumen catheters can be inserted right during procedures to enable independent venous access. They are frequently made of polyethylene or polyurethane material. It enables the simultaneous injection of two incompatible liquids or medicines. It has a number of benefits, including the perfect combination of flexibility and toughness, which makes it a popular lumen type for hemodialysis operations.

    Market Dynamics

    Furthermore, according to a 2019 study referenced by the NHS, chronic kidney disease is associated with high blood pressure, cholesterol, kidney infections, and kidney stones. According to research released by the CDC, more than 94 million Americans aged 20 or older have excessive cholesterol, with total cholesterol levels above 200 mg/dL. Thus, the market is expected to grow at a significant rate.

    The need and demand for hemodialysis catheters are rising as a result of the rising prevalence of chronic kidney disorders and end-stage renal disease, supportive initiatives to raise awareness of chronic kidney disorders, rising use of renal replacement therapy, technological advancements in hemodialysis catheters, and a global shortage of kidney donors.

    In the United States, end-stage renal illness was estimated to affect 786,000 people in 2021. (ESRD). Global chronic kidney disease rates are rising as a result of the occurrence of diabetes mellitus, hypertension, obesity, and ageing. There are still some places where illnesses, natural remedies, and environmental poisons are typical causes. Consequently, the industry environment will be greatly influenced by the exceptional rise in the prevalence of CKD and ESRD.

    The use of hemodialysis catheters, however, can present a number of difficulties that could impede market expansion. The most frequent side effects are thrombosis, edema, bleeding, aneurysms, and infections. Over 24% of the patients reported difficulties in a dataset of 212 individuals who were included in a 2019 study about complications of hemodialysis catheterization that was published in the National Centre of Biotechnology Information (NCBI). As a result, the procedure's cost-effectiveness may be compromised and extended hospital stays may result in hampering the market growth. Moreover, product recalls can also hinder market growth. For instance, in August 2022, Covidien, LLC (Medtronic) recalls Palindrome and Mahurkar hemodialysis catheters due to a catheter hub defect.

    Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:

    One of the major variables fueling the market's expansion during the analysis period is the rise in the prevalence of ESRD and chronic kidney disorders. For example, according to a recent report, the prevalence of chronic kidney disease (CKD) worldwide is predicted to be 13.4% in 2019, with an estimated 4.9 to 7 million people needing renal replacement therapy. Additionally, the CDC in a recent report, confirms that over 360 patients in the United States are getting ready to start dialysis every 24 hours for kidney failure and that there are approximately 37 million adults who have CKD, many of whom go undiagnosed.

    Segments Analysis

    By Cathether Type

    The segment is bifurcated into short-term hemodialysis catheters, and long-term hemodialysis catheters. Short-term hemodialysis catheters have many benefits, including ease of insertion in unstable patients, less problems, an extended functional life, and patient comfort, among others. This has resulted in the rapid rise of the short-term catheter market. These catheters are designed to meet the clinical needs of patients receiving high-pressure contrast injections as well as hemodialysis, infusion, apheresis, and monitoring of primary venous pressure. The widespread use of these devices is attributable to the rise in acute kidney problems brought on by infection, liver failure, heart failure, severe blood loss, etc. The main causes of acute renal disorders, which in severe cases can result in morbidity or fatality, is liver failure.

    By Product Type

    The segment is divided into tunnelled catheters and non-tunnelled catheters. The tunnelled catheters segment is further divided into cuffed and non-cuffed. In 2021, the segment of tunnelled catheters held the majority of the market share. This is mostly attributable to the fact that tunnelled hemodialysis catheters have a lower infection rate than non-tunneled catheters.

    Regional Analysis

    The hemodialysis catheters market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2021, North America is anticipated to be the hemodialysis catheters market's largest region. By 2028, the market for hemodialysis catheters in the US is expected to expand significantly. The growing prevalence of renal illnesses and scarcity of kidney donors in the area are the main causes of the market's sizeable revenue share. Renal failure is said to be the end consequence of most renal disorders as they advance. Patients needing kidney transplants must wait longer due to a shortage of kidney donors. These patients receive hemodialysis treatment. A lot more than 90,000 patients are on the waiting list for kidney transplants, but only about 20,000 are actually performed each year, according to a Penn Medicine study from 2020. On the transplant waiting list, about 5,000 people pass away yearly without receiving a transplant.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The following are the major players in the hemodialysis catheters market:

    • AdvaCare Pharma
    • AngioDynamics
    • Argon Medical Devices
    • Argon Medical Devices
    • B Braun Melsungen AG
    • Bain Medical Equipment (Guangzhou) Co., Ltd.
    • Baxter
    • BD
    • Cook Medical
    • Joline GmbH & Co. KG
    • Lepu Medical Technology
    • MedComp
    • Medtronic plc
    • Merit Medical
    • Poly Medicure Ltd
    • Teleflex
    • Vygon

    Hemodialysis catheters are subject to fierce rivalry. Industry circumstances and government backing have a direct impact on the companies' ability to grow. Based on their quality and market penetration in both the target and growing markets, these companies distinguish their hemodialysis catheters from competitors' offerings. Additionally, a few notable industry mergers and acquisitions in recent years have had a big impact on the dynamics of competition.

    • The U.S. Food and Drug Administration (FDA) granted the Pristine Long-Term Hemodialysis Catheter, a brand-new hemodialysis catheter with a special side-hole free symmetric Y-Tip distal lumen design, 510(k) approval in April 2021. BD is a prominent worldwide medical technology firm. The device was created by the Israeli business Pristine Access Technologies, Ltd.
    • In October 2022, Medtronic acquired US-based privately held medical device company Avenu Medical. For end-stage renal disease (ESRD) patients receiving dialysis, Avenu Medical focuses on producing arteriovenous (AV) fistulae using minimally invasive endovascular techniques. By joining an arm vein and artery, AV fistulae make it easier to administer dialysis therapy. The Ellipsys Vascular Access System from Avenu Medical is a single-catheter, ultrasound-guided tool. To generate a long-lasting AV fistula, the gadget inserts the catheter through the skin into the arm.

    The overall competitive landscape has been affected due to these mergers and acquisitions. 

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Hemodialysis Catheters Market 

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The hemodialysis catheters market is estimated to reach at US$ ~1140 million in 2028.

    The hemodialysis catheters market is growing at a CAGR of 4.8% over the forecast period.

    AdvaCare Pharma, AngioDynamics, Argon Medical Devices, Argon Medical Devices, B Braun Melsungen AG, Bain Medical Equipment (Guangzhou) Co., Ltd., Baxter, BD, Cook Medical, Joline GmbH & Co. KG, Lepu Medical Technology, MedComp, Medtronic plc, Merit Medical, Poly Medicure Ltd, Teleflex, Vygon.

    The hemodialysis catheters market is studied from 2016 - 2028.

    A hemodialysis catheter is a piece of medical equipment that is put into the body during hemodialysis to reach the intravascular area. A specific filter called a dialyzer is where the blood from the body is cleansed before being returned to the body through the hemodialysis catheter.

    The need and demand for hemodialysis catheters are rising as a result of the rising prevalence of chronic kidney disorders and end-stage renal disease, supportive initiatives to raise awareness of chronic kidney disorders, rising use of renal replacement therapy, technological advancements in hemodialysis catheters, and a global shortage of kidney donors.

    North America is anticipated to be the hemodialysis catheters market's largest region. By 2028, the market for hemodialysis catheters in the US is expected to expand significantly. The growing prevalence of renal illnesses and scarcity of kidney donors in the area are the main causes of the market's sizeable revenue share.